Charles River Laboratories International, Inc. (CRL)
186.36
+5.02
(+2.77%)
USD |
NYSE |
Jun 08, 16:00
186.36
0.00 (0.00%)
After-Hours: 20:00
Charles River Laboratories International EPS Diluted (Quarterly) : -0.3032 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fortrea Holdings, Inc. | -0.2521 |
| IQVIA Holdings, Inc. | 1.614 |
| Inotiv, Inc. | -0.9369 |
| Medpace Holdings, Inc. | 4.277 |
| Champions Oncology, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.80M |
| Revenue (Quarterly) | 995.83M |
| Total Expenses (Quarterly) | 1.011B |
| Enterprise Value | 11.65B |
| Gross Profit Margin (Quarterly) | 30.90% |
| Profit Margin (Quarterly) | -1.49% |
| Earnings Yield | -2.02% |
| Operating Earnings Yield | 5.70% |
| Normalized Earnings Yield | 1.666 |